{"id":"NCT05579730","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis","officialTitle":"Evaluation of Combination Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution Compared to Its Components and Vehicle for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge Model","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-10-12","primaryCompletion":"2023-07-22","completion":"2023-07-22","firstPosted":"2022-10-14","resultsPosted":"2025-02-14","lastUpdate":"2025-02-14"},"enrollment":188,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Conjunctivitis"],"interventions":[{"type":"DRUG","name":"Brimonidine tartrate 0.025%/ketotifen fumarate 0.035%","otherNames":[]},{"type":"DRUG","name":"Brimonidine Tartrate 0.025%","otherNames":[]},{"type":"DRUG","name":"Ketotifen Fumarate 0.035%","otherNames":[]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"Combination","type":"EXPERIMENTAL"},{"label":"Ketotifen fumarate","type":"ACTIVE_COMPARATOR"},{"label":"Brimonidine tartrate","type":"ACTIVE_COMPARATOR"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy of Combo (Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution) compared to its individual components and vehicle in a population of subjects with allergic conjunctivitis:","primaryOutcome":{"measure":"Ocular Itching","timeFrame":"Assessed at Visit 4b on day 1 (duration of action CAC at 8 hours post-instillation of study medication) and Visit 5 on day 15 (onset of action CAC at 15 minutes post-instillation of study medication).","effectByArm":[{"arm":"Combination","deltaMin":1.176,"sd":0.1464},{"arm":"Ketotifen Fumarate","deltaMin":1.708,"sd":0.1487},{"arm":"Brimonidine Tartrate","deltaMin":2.426,"sd":0.133},{"arm":"Vehicle","deltaMin":2.362,"sd":0.1512}],"pValues":[]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":47},"commonTop":["Visual Acuity reduced","Nasopharyngitis","Skin laceration","Conjunctival haemorrhage","Conjunctivitis allergic"]}}